527. A Descriptive, Retrospective Analysis of COVID-19 Antibody Therapy and its Effects on Morbidity and Mortality in Patients Receiving B-cell Depleting Therapies

BACKGROUND: Patients receiving B-cell-depleting therapies (BCDT) are at an increased risk for severe COVID-19. Passive antibody therapy (PAT), including COVID-19 convalescent plasma (CCP) and monoclonal antibodies (MAB), is hypothesized to be an effective treatment in this population. However, real-...

Descripción completa

Detalles Bibliográficos
Autores principales: SIMEUNOVIC, G O R D A N A, Sullivan, Liam R, Brooks, Heather, Gentile, Sonia K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677108/
http://dx.doi.org/10.1093/ofid/ofad500.596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677108/
http://dx.doi.org/10.1093/ofid/ofad500.596

Ejemplares similares